Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Raysearch Laboratories

225,00 SEK

+0,22 %

Mindre end 1K følgere

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+0,22 %
-12,28 %
-5,06 %
-31,61 %
+4,17 %
+9,22 %
+300,36 %
+191,07 %
+303,40 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Læs mere
Markedsværdi
7,71 mia. SEK
Aktieomsætning
11,69 mio. SEK
Omsætning
1,19 mia.
EBIT %
21,85 %
P/E
37,88
Udbytteafkast, %
1,33 %
Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
12.2
2026

Årsrapport '25

29.4
2026

Delårsrapport Q1'26

7.5
2026

Generalforsamling '26

Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse28.11.2025, 11.45

From Image-Guided Ablation to Radiology Workstation: RaySearch Showcases Next-Level Innovations at RSNA 2025

Raysearch Laboratories
Pressemeddelelse10.11.2025, 08.47

Redeye: RaySearch Laboratories (Q3 Review) - EBIT beat reinforces take on conservative targets

Raysearch Laboratories
RaySearch Laboratories, Audiocast, Q3'25
Videopræsentation7.11.2025, 09.00

RaySearch Laboratories, Audiocast, Q3'25

Raysearch Laboratories

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse7.11.2025, 06.45

Interim report third quarter 2025: Record high net sales and strong long-term performance

Raysearch Laboratories
Pressemeddelelse29.10.2025, 13.35

RaySearch receives additional RayStation order for advanced proton therapy at Stanford Health Care

Raysearch Laboratories
Pressemeddelelse23.10.2025, 08.00

Invitation to presentation of RaySearch’s interim report for the third quarter of 2025

Raysearch Laboratories
Pressemeddelelse26.9.2025, 07.30

RaySearch Laboratories: RaySearch Brings Next-Level Innovation to ASTRO 2025

Raysearch Laboratories
Pressemeddelelse1.9.2025, 09.25

RaySearch Laboratories: RaySearch launches RayIntelligence® v2025

Raysearch Laboratories
Pressemeddelelse28.8.2025, 07.45

RaySearch Laboratories: Proton center in South Korea selects RayStation and RayCare

Raysearch Laboratories
Pressemeddelelse12.8.2025, 10.14

Redeye: RaySearch Q2 - Gearing up for more record quarters

Raysearch Laboratories
Selskabsmeddelelse8.8.2025, 05.45

RaySearch Laboratories: Interim report April - June 2025

Raysearch Laboratories
Pressemeddelelse25.7.2025, 06.30

RaySearch Laboratories: RaySearch to present innovative news in RayStation, RayCare, and RayIntelligence at AAPM 2025

Raysearch Laboratories
Pressemeddelelse21.7.2025, 06.30

RaySearch Laboratories: AKSM/Oncology selects RayCare and RayStation for a new cancer center

Raysearch Laboratories
Pressemeddelelse18.7.2025, 13.57

RaySearch Laboratories: RaySearch and Radiology Oncology Systems in strategic partnership to expand access to cancer care

Raysearch Laboratories
Pressemeddelelse18.7.2025, 07.22

RaySearch Laboratories: Invitation to presentation of RaySearch's interim report for the second quarter of 2025

Raysearch Laboratories
Pressemeddelelse27.6.2025, 11.00

RaySearch Laboratories: RaySearch releases RayCare v2025

Raysearch Laboratories
Pressemeddelelse16.6.2025, 07.37

RaySearch Laboratories: RayStation used for pioneering clinical milestone at Helsinki University Hospital - first treatment with accelerator-based BNCT in Europe

Raysearch Laboratories
Pressemeddelelse2.6.2025, 10.51

RaySearch Laboratories: RaySearch to present advanced software innovations for particle therapy at PTCOG 63

Raysearch Laboratories
Selskabsmeddelelse22.5.2025, 18.35

RaySearch Laboratories: Bulletin from the Annual General Meeting 2025

Raysearch Laboratories
Pressemeddelelse12.5.2025, 08.27

Redeye: RaySearch Laboratories Q1 - Demonstrating a strong profitability outlook

Raysearch Laboratories
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.